The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells
Open accessAbstract
The immunosuppressive drugs rapamycin and cyclosporin A (CsA) are widely used to prevent allograft rejection. Moreover, they were shown to be instrumental in experimental models of tolerance induction. However, it remains to be elucidated whether these drugs have an effect on the CD4+ CD25+ regulatory T-cell (T(REG)) population, which plays an important role in allograft tolerance. Recently, we reported that alloantigen-driven expansion of human CD4+ CD25+ T(REG)s gives rise to a distinct highly suppressive CD27+ T(REG) subset next to a moderately suppressive CD27- T(REG) subset. In the current study we found that rapamycin and CsA do not interfere with the suppressive activity of human naturally occurring CD4+ CD25+ T cells. However, in contrast to CsA, rapamycin preserved the dominance of the potent CD27+ T(REG) subset over the CD27- T(REG) subset after alloantigen-driven expansion of CD4+ CD25+ T(REG)s in vitro. Accordingly, CD4+ CD25+ T(REG)s cultured in the presence of rapamycin displayed much stronger suppressive capacity than CD4+ CD25+ T(REG)s cultured in the presence of CsA. In addition, CD4+ CD25+ T(REG) cells cultured in the presence of rapamycin, but not CsA, were able to suppress ongoing alloimmune responses. This differential effect of rapamycin and CsA on the CD27+ T(REG) subset dominance may favor the use of rapamycin in tolerance-inducing strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and has also been shown to selectively preserve the development of Tregs, 172”
From Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: Review of the literature and personalized risk-based prevention strategy (2020) · cites this paper as [172]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature reviews. Immunology · doi:10.1038/nri821 · Cited by 2,097
Regulatory T cells in transplantation tolerance
Wood, K. J., & Sakaguchi, S. (2003) · Nature reviews. Immunology · doi:10.1038/nri1027 · Cited by 1,319
Edinger, M., Hoffmann, P., Ermann, J., Drago, K., Fathman, C. G., Strober, S., & Negrin, R. S. (2003) · Nature Medicine · doi:10.1038/nm915 · Cited by 1,286
In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes
Tang, Q., Henriksen, K., Bi, M., Finger, E. B., Szot, G. L., Ye, J., Masteller, E. L., McDevitt, H. O., Bonyhadi, M. L., & Bluestone, J. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040139 · Cited by 1,232
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.
Battaglia, M., Stabilini, A., & Roncarolo, M. (2005) · Blood · doi:10.1182/blood-2004-10-3932 · Cited by 1,203
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Croft, M. (2003) · Nature reviews. Immunology · doi:10.1038/nri1148 · Cited by 863
Li, Y.-S., Li, X.-C., Zheng, X., Wells, A., Turka, L., & Strom, T. (1999) · Nature Medicine · doi:10.1038/15256 · Cited by 830
Tolerance, not immunity, crucially depends on IL-2
Malek, T. R., & Bayer, A. L. (2004) · Nature reviews. Immunology · doi:10.1038/nri1435 · Cited by 819
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A., Morris, P. J., Powrie, F. M., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 765
Kingsley, C. I., Karim, M., Bushell, A., & Wood, K. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1080 · Cited by 742
Cited by
Sorted by citations
Items 201–254 of 254
Jiang, S., Lechler, R. I., He, X.-S., & Huang, J.-F. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.10.1003 · Cited by 6
Korecka, A., Bocian, K., Pachówka, M., Jałbrzykowska, A., & Korczak-Kowalska, G. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0388-8 · Cited by 5
Korczak-Kowalska, G., Stelmaszczyk‐Emmel, A., Bocian, K., Kiernozek, E., Drela, N., & Domagala-Kulawik, J. J. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0471-9 · Cited by 7
Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients
Fadel, F. I., Bazaraa, H. M., Salah, D. M., Elghoroury, E. A., Ibrahim, M. H., Nasr, S. A., Elshamaa, M. F., Koura, H. M., Kassem, N. M. A., & El-Saeed, G. S. M. (2015) · International Journal of Biomedical Science · doi:10.59566/ijbs.2015.11121 · Cited by 5
Automated GMP-compatible production of universal CAR Tregs for organ-targeted tolerance induction
Lakshmi, K., von Jutrzenka-Trzebiatowski, A., Loureiro, L. R., Soto, K. E. G., Peter, K., Morales, J. M. M., Nirmala, S. S., Berndt, N., Arndt, C., Hu, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07431-0 · Cited by 4
Ayuk, F. A., Wagner-Drouet, E., Wolff, D., von Hünerbein, N., von Pein, U., Klyuchnikov, E., von Harsdorf, S., Koenecke, C., Sayer, H. G., & Kröger, N. M. (2024) · Bone Marrow Transplantation · doi:10.1038/s41409-024-02289-0 · Cited by 4
Células T reguladoras y tolerancia en trasplante: Efecto de la inmunosupresión farmacológica
Segundo, D. S., Benito, M. J., Fernández‐Fresnedo, G., Marín, M. J., Arias, M., López‐Hoyos, M., & Thielens, N. M. (2007) · Inmunología · doi:10.1016/s0213-9626(07)70085-9 · Cited by 4
Tolerance in clinical liver transplantation
Cortesini, R. (2006) · Transplant Immunology · doi:10.1016/j.trim.2006.11.001 · Cited by 4
The Effects of Immunosuppression on Regulatory CD4+CD25+ T Cells
Javeed, A., & Zhao, Y. X. (2008) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256281 · Cited by 3
Gilman, K. E., Cracchiolo, M. J., Matiatos, A. P., Davini, D. W., Simpson, R. J., & Katsanis, E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1045710 · Cited by 3
O-Glycosylation of NnTreg Lymphocytes Recognized by theAmaranthus leucocarpusLectin
Martínez, M. D. C. J., Lascuraín, R., Méndez-Reguera, A., Estrada-Parra, S. A., Estrada‐García, I., Gorocica, P., Martínez-Cairo, S., Zenteno, E., & Chávez, R. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/506807 · Cited by 3
Zhao, Y. X. (2007) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.3.3.245 · Cited by 3
López‐Hoyos, M., Segundo, D. S., & Brunet, M. (2016) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000265 · Cited by 3
Wallace, C. G., Yen, C.-H., Yang, H.-C., Lin, C., Wu, R., Huang, W.-C., Lin, J.-Y., & Wei, F. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/704063 · Cited by 3
Elmariah, H., & Bolaños‐Meade, J. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-84988-6_5 · Cited by 2
CD25+CD27+CD70− alloantigen-specific Tregs: promising stable immunotherapy for transplantation
Cortés-Hernández, A., Arteaga-Cruz, S., Martínez-Iturbe, I., Rosas-Cortina, K., Mora, M. A. V., Legorreta-Anguiano, E., Reyes-Barrientos, J. E., Alvarez-Salazar, E. K., Cervera, A., Sánchez-Hernández, B. E., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1789008 · Cited by 2
de Freitas, G. R. R., Fernandes, M. D. L., Agena, F., Lemos, F. B. C., de Paula, F. J., Coelho, V. P. C. V., David-Neto, E., & Galante, N. Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405855 · Cited by 2
Timrott, K., Vondran, F. W. R., Bektas, H., Klempnauer, J. L., & Jäger, M. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119950 · Cited by 2
Diltiazem induces regulatory T cellsin vitroby modulating human dendritic cell maturation
Pugliese, O., D’Ambrosio, A., Campanile, D., & Quintieri, F. (2011) · Transplant International · doi:10.1111/j.1432-2277.2010.01210.x · Cited by 2
Highlights in Cellular and Molecular Mechanisms of Allergic Diseases
Basinski, T. M., Özdemir, C., Saçkesen, C., Mantel, P., Barlan, I. B., Akdiş, M., Jutel, M., & Akdiş, C. A. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000096113 · Cited by 2
Rodriguez, N. T., Lee, J., Flynn, L., Murray, F., Devlin, S. M., Soto, C., Cho, C., Dahi, P. B., Giralt, S. A., Perales, M., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.05.008 · Cited by 2
Regulatory T cell therapy in lung transplantation: bridging the gap from bench to bedside
Li, Q., Li, G., Feng, J., & Zhang, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1654561 · Cited by 1
After Moving of Regulatory T-Cell Therapy to the Clinic: Will We Need a New Tregs Source?
Elbadry, M. I. (2017) · Hematology & Transfusion International Journal · doi:10.15406/htij.2017.05.00117 · Cited by 1
Role for primary immunosuppression with everolimus after pulmonary transplantation
Salman, J., Jansson, K., Siemeni, T., Sommer, W., Knoefel, A.-K., Ahrens, L., Nakagiri, T., Ius, F., Tudorache, I., Kruse, B., et al. (2018) · Transplant Immunology · doi:10.1016/j.trim.2018.03.005 · Cited by 1
Pediatric Lung Transplantation
Potera, R. M., & Huddleston, C. B. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6359-6_28 · Cited by 1
Онищенко, Н. А., Башкина, Л. В., Nicolskaya, A. O., & Артамонов, С. Д. (2014) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2013-4-112-125 · Cited by 1
Thornton, A. M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00605-9 · Cited by 1
Prospects for the Induction of Transplant Tolerance Using Dendritic Cells
Buckland, M. S., Smyth, L. A., Lechler, R. I., & Lombardi, G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5480-9_13
Immunosuppressive Drugs and Immune Regulation in Organ Transplantation
Sewgobind, V. D. K. D. (2010) · RePub (Erasmus University Rotterdam)
Uso de inhibidores de proteosoma como profilaxis de enfermedades de injerto contra huesped
Caballero‐Velázquez, T. (2010) · doi:10.14201/gredos.83197
Arribas, D. S. S. (2010) · UCrea (University of Cantabria)
Dynamics of Regulatory T cells in Liver Transplantation
Demerkiran, A. (2007) · RePub (Erasmus University Rotterdam)
The Role of Regulatory T cells in Kidney Transplantation
Hendrikx, T. K. (2009) · RePub (Erasmus University Rotterdam)
Néphropathie et entéropathies autoimmunes : rôle des cellules T régulatrices CD4+CD25+FOXP3+
Zuber, J. (2007) · Néphrologie & Thérapeutique · doi:10.1016/j.nephro.2007.09.004
Regulatory T cells and immune tolerance after allogeneic hematopoietic stem cell transplantation
Bruinsma, M. (2010) · RePub (Erasmus University Rotterdam)
SA-4-1BBL as a modulator of T effector to T regulatory cell conversion.
Madireddi, S. (2010) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/880
Approaches to the Induction of Tolerance
Wood, K. J., & Geissler, E. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00021-8
Cellule T-regolatorie nel trapianto di rene.
Libetta, C., Portalupi, V., Margiotta, E., Sepe, V., Canevari, M., Meloni, F., Morosini, M., & Canton, A. D. (2009) · Giornale Italiano di Nefrologia
Approaches to the Induction of Tolerance
Nadig, S. N., Warnecke, G., & Wood, K. J. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-3343-1.50027-x
Tolerancia Inmunologica en trasplante renal
Gómez, F. M. H. (2014) · doi:10.35376/10324/8548
Sayegh, M. H. (2008) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1108081.564063
Expressão dos linfócitos CD4+CD25+ (células T reguladoras) nos pênfigos
de Albuquerque, C. M. (2014) · doi:10.11606/t.17.2014.tde-16072024-154817
Regulatory T-cells in Therapeutic Transplantation Tolerance
Waldmann, H., Adams, E., Fairchild, P. J., & Cobbold, S. P. (2008) · Springer eBooks · doi:10.1007/978-0-387-77909-6_17
Dao, T. T. A., & ダオ, チ. タ. ア. (n.d.) · Institutional Repositories DataBase (IRDB)
Impact des inhibiteurs de la voie mTOR sur la réponse immunitaire T anti-tumorale
Beziaud, L. (2015) · theses.fr (ABES) · doi:10.70675/02936eacz6998z4fd1zb56cz2535d854411e
Preclinical development of a T cell based gene therapy to treat IPEX syndrom
Delville, M. (2019) · theses.fr (ABES) · doi:10.70675/a98fdc5dz0036z4620z848ez66c60ea7bd96
Chou, C., Wang, X., Yu, R., Xu, H., Chen, Y., Yang, Y., Chen, Z., Li, C., He, T., & Chen, X. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02990-1
Litjens, N. H. R., Jonker, J., Klepper, M., Prevoo, F., Hesselink, D. A., Bemelman, F. J., Nurmohamed, A. S., van Zuilen, A. D., Berger, S. P., Sanders, J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1904559
Wong, J., Kuppan, P., Cuesta‐Gomez, N., Lin, J., Paramor, J., Castro, C., Polishevska, K., Bose, A. K., Anderson, C. C., Korbutt, G. S., et al. (2026) · American Journal of Transplantation · doi:10.1016/j.ajt.2026.10.025
Romano, M. (2015) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6784
Metadata
- Authors
- Coenen, J. J. A., Koenen, H. J. P. M., van Rijssen, E., Hilbrands, L. B., & Joosten, I.
- Affiliations
- Radboud University Medical Center (NL)
- From the Department of Bloodtransfusion and Transplantation Immunology and the Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2006-02-01
- Volume
- 107
- Issue
- 3
- Pages
- 1018-1023
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1972290737
- Cited by
- 252
- References
- 38
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 6 · 2019: 4 · 2018: 4 · 2017: 14 · 2016: 9 · 2015: 13 · 2014: 14 · 2013: 8 · 2012: 21
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Nierstichting
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- rapamycin, cyclosporine, regulatory T cells, CD4+CD25+ T cells, immunosuppressants, allograft tolerance, suppressor activity, mTOR inhibition
- MeSH terms
- Cells, Cultured, Dose-Response Relationship, Drug, Graft Rejection, Humans, Immune Tolerance, Immunosuppressive Agents, Isoantigens, Lymphocyte Activation, Transplantation, Homologous, Cyclosporine, Tumor Necrosis Factor Receptor Superfamily, Member 7, Sirolimus, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
